Monlutenca 40 GBq/ml radiopharmac. precursor sol. i.v. vial Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

monlutenca 40 gbq/ml radiopharmac. precursor sol. i.v. vial

monrol europe s.r.l. - lutetium (lu-177) chloride 40 gbq/ml - radiopharmaceutical precursor, solution - other therapeutic radiopharmaceuticals

SANDOSTATIN 500 microgram/1 ml, solution for injection/infusion Malta - Kiingereza - Medicines Authority

sandostatin 500 microgram/1 ml, solution for injection/infusion

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - octreotide - solution for infusion or injection - octreotide 0.5 mg/ml - pituitary and hypothalamic hormones and analogues

SANDOSTATIN LAR 10 mg powder and solvent for suspension for injection Malta - Kiingereza - Medicines Authority

sandostatin lar 10 mg powder and solvent for suspension for injection

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - octreotide - powder and solvent for suspension for injection - octreotide 10 mg - pituitary and hypothalamic hormones and analogues

SANDOSTATIN LAR 20 mg powder and solvent for suspension for injection Malta - Kiingereza - Medicines Authority

sandostatin lar 20 mg powder and solvent for suspension for injection

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - octreotide - powder and solvent for suspension for injection - octreotide 20 mg - pituitary and hypothalamic hormones and analogues

SANDOSTATIN LAR 30 mg powder and solvent for suspension for injection Malta - Kiingereza - Medicines Authority

sandostatin lar 30 mg powder and solvent for suspension for injection

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - octreotide - powder and solvent for suspension for injection - octreotide 30 mg - pituitary and hypothalamic hormones and analogues

SANDOSTATIN 100 microgram/1ml, solution for injection/infusion Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

sandostatin 100 microgram/1ml, solution for injection/infusion

novartis ireland limited - octreotide - solution for injection/infusion - 100 microgram(s)/millilitre - somatostatin and analogues; octreotide

SANDOSTATIN 50 microgram/1 ml, solution for injection/infusion Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

sandostatin 50 microgram/1 ml, solution for injection/infusion

novartis ireland limited - octreotide - solution for injection/infusion - 50 microgram(s)/millilitre - somatostatin and analogues; octreotide

SANDOSTATIN 500 microgram/1 ml, solution for injection/infusion Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

sandostatin 500 microgram/1 ml, solution for injection/infusion

novartis ireland limited - octreotide - solution for injection/infusion - 500 microgram(s)/millilitre - somatostatin and analogues; octreotide

Sandostatin LAR 10 mg powder and solvent for suspension for injection Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

sandostatin lar 10 mg powder and solvent for suspension for injection

novartis ireland limited - octreotide - powder and solvent for suspension for injection - 10 milligram(s) - somatostatin and analogues; octreotide

Sandostatin LAR 20 mg powder and solvent for suspension for injection Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

sandostatin lar 20 mg powder and solvent for suspension for injection

novartis ireland limited - octreotide - powder and solvent for suspension for injection - 20 milligram(s) - somatostatin and analogues; octreotide